Patents by Inventor Felix Lai

Felix Lai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PCBP1 TO TREAT HYPERPROLIFERATIVE DISEASE
    Publication number: 20250057978
    Abstract: The present disclosure provides compositions and methods of using gene therapy to decrease cell migration and metastasis and reduce tumor mass or burden. The methods disclosed herein employ plasmids, vectors, and non-viral vectors that contain PCBP1 and/or PCBP1 mutants which inhibit the expression of cancer biomarkers and decrease cell migration or tumor size.
    Type: Application
    Filed: April 4, 2024
    Publication date: February 20, 2025
    Inventors: Norman Zhennan LAI, Michael Joseph Karlin, Alberto Murat Croci, Vidal Felix De La Cruz, JR., Yuebin Tan
  • COMPOSITIONS OF PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR
    Publication number: 20240254180
    Abstract: The present invention relates to compositions of peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt or solvate forms thereof, corresponding pharmaceutical compositions, methods and/or uses for treatment of autoimmune inflammation and related diseases and disorders.
    Type: Application
    Filed: January 25, 2024
    Publication date: August 1, 2024
    Inventors: Giustino DI PRETORO, Dajun SUN, Gopal RAJAN, Geraldine BROECKX, Nathalie MERTENS, Shu LI, Felix LAI, Mohammad MASJEDIZADEH, Anne M. FOURIE, Beverly KNIGHT, David POLIDORI, Santhosh Francis NEELAMKAVIL, Nishit MODI, Ashok BHANDARI, Xiaoli CHENG
  • Compositions of peptide inhibitors of Interleukin-23 receptor
    Patent number: 11939361
    Abstract: The present invention relates to compositions of peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt or solvate forms thereof, corresponding pharmaceutical compositions, methods and/or uses for treatment of autoimmune inflammation and related diseases and disorders.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: March 26, 2024
    Assignees: Janssen Pharmaceutica NV, Protagonist Therapeutics, Inc.
    Inventors: Giustino Di Pretoro, Dajun Sun, Gopal Rajan, Geraldine Broeckx, Nathalie Mertens, Shu Li, Felix Lai, Mohammad Masjedizadeh, Anne M. Fourie, Beverly Knight, David Polidori, Santhosh Francis Neelamkavil, Nishit Modi, Ashok Bhandari, Xiaoli Cheng
  • COMPOSITIONS OF PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR
    Publication number: 20220177532
    Abstract: The present invention relates to compositions of peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt or solvate forms thereof, corresponding pharmaceutical compositions, methods and/or uses for treatment of autoimmune inflammation and related diseases and disorders.
    Type: Application
    Filed: November 19, 2021
    Publication date: June 9, 2022
    Inventors: Giustino Di Pretoro, Dajun SUN, Gopal RAJAN, Geraldine BROECKX, Nathalie MERTENS, Shu LI, Felix LAI, Mohammad MASJEDIZADEH
  • MULTIPARTICULATE SELECTIVE SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR FORMULATION
    Publication number: 20100040680
    Abstract: A multiparticulate oral pharmaceutical composition that contains a plurality of delayed release coated selective serotonin and norepinephrine reuptake inhibitor particles.
    Type: Application
    Filed: August 15, 2008
    Publication date: February 18, 2010
    Inventors: Felix Lai, Richard Ting, Christopher A. Simpson, Victoria Kellogg, Sibel Ucpinar
  • Data analysis flow engine
    Patent number: 7093207
    Abstract: An extensible data analysis system for analyzing integrated circuit fabrication data produced during integrated circuit fabrication, including an application tier that selectively runs analysis nodes. The application tier has an architecture for optionally including and excluding a desired selection of the analysis nodes. The application tier architecture allows the selection of the analysis nodes to be dynamically added by a user. A data access tier selectively runs data reader nodes. The data access tier has an architecture for optionally including and excluding a desired selection of the data reader nodes. The data reader nodes interpret a desired variety of data source files containing the integrated circuit fabrication data having different formats for access by the application tier. The data access tier architecture allows the selection of the data reader nodes to be dynamically added by the user.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: August 15, 2006
    Assignee: KLA-Tencor Technologies Corporation
    Inventors: Po-Shou Liao, Benny Huang, Charles Lai, Jimmy Liao, Bing Li, Ilya Languev, Peter Eldredge, Leslie F. Smith, Felix Lai, Sino Ho, Ellis E-Li Chang, Sandeep Bhagwat, Anthony Cheung, Michael J. Bellon
  • [A LCD LIGHTING CONTROL SYSTEM]
    Publication number: 20050248523
    Abstract: A LCD lighting control system comprises a lamp, a self-oscillation inverter, a sampling-frequency generating circuit, a detecting-feedback circuit, a modulator and a buck circuit. The LCD lighting control system samples at the preset sampling location in the self-oscillation inverter or the preset sampling location between the self-oscillation inverter and the buck circuit to synchronize the control signal from the modulator and the self-oscillation frequency, to suppress high-voltage ripple effect, and to enhance stability of the system.
    Type: Application
    Filed: August 12, 2004
    Publication date: November 10, 2005
    Inventors: Andre Yu, Tim Yu, Jason Lee, Felix Lai, Bill Huang